[Current status of tetanus prevention].
D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000150:complications; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D007115:Immunization Schedule; D007116:Immunization, Passive; D007223:Infant; D010507:Periodicity; D012900:Smallpox Vaccine; D013742:Tetanus / Q000209:etiology / Q000517:prevention & control*; D013743:Tetanus Antitoxin / Q000097:blood; D013745:Tetanus Toxoid / Q000009:adverse effects / Q000627:therapeutic use; D014611:Vaccination / Q000009:adverse effects; D014946:Wound Infection / Q000150:complications; D014947:Wounds and Injuries / Q000150:complications
D012900:Smallpox Vaccine; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid
Zum aktuellen Stand der Tetanus-Prophylaxe